Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Krystal Biotech, Inc. (KRYS) News - StockMarketCap

Stocks›Krystal Biotech, Inc.☆

● At closeAs of Jul 2, 2026

Krystal Biotech, Inc.

KRYS✓

HealthcareBiotechnologyNASDAQ

$375.07+0.94%

$11.06BMarket cap

48.48xP/E ratio

235.20KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$375.07

$3.49 (+0.94%) · 24h

Key metrics

Market cap$11.06B+24.68%

Enterprise value$10.58B

Volume (24h)235.20K

P/E ratio (TTM)48.48x

P/S ratio (TTM)26.54x

Dividend yield0.00%

Shares outstanding29.48M

Trading range

Previous close$371.58

Day range$365.47 - $377.35

52-week range$130.50 - $382.54

Krystal Biotech, Inc. (KRYS) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news